3billion, Inc.Z5.D49At 3billion, we provide NGS-based genetic testing services for patients with rare diseases. Our innovative technology is transforming traditional diagnostic methods, enabling faster and more efficient diagnosis of patient suffering from unknown diseases.
[Our Services]
Whole Exome/Genome-Based Clinical Testing: Certified under CLIA and CAP standards, ensuring the highest quality and reliability
Variant Interpretation Services: Comprehensive analysis and reporting of genetic variants.
Variant Interpretation Software: Cutting-edge tools designed to streamline and enhance genetic variant interpretation.
Operating in over 70 countries, 3billion has delivered full genetic testing services to more than 70,000 patients worldwide. Through global partnerships, we are committed to advancing the field of genetic testing and improving patient outcomes.